Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Audia

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Cold Spring Harbor Perspectives in Biology|April 3, 2016
Histone Modifications and CancerJames E Audia, Robert M Campbell
ACS Medicinal Chemistry Letters|March 19, 2020
Mentoring Matters in Drug DiscoveryMaria-Jesus Blanco, James E Audia
Life Sciences|July 11, 2002
Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in catsMary A Katofiasc, Jeffrey Nissen, James E Audia, et al.
Journal of Virology|March 18, 2021
Ilaprazole and other novel prazole-based compounds that bind Tsg101 inhibit viral budding of HSV-1/2 and HIV from cellsJonathan Leis, Chi-Hao Luan, James E Audia, et al.
The Journal of Organic Chemistry|November 1, 1996
"Pictet-Spengler-like" Synthesis of Tetrahydro-beta-carbolines under Hydrolytic Conditions. Direct Use of Azalactones as Phenylacetaldehyde EquivalentsJames E. Audia, James J. Droste, Jeffrey S. Nissen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 19, 2005
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brainVirginia L Lucaites, Joseph H Krushinski, John M Schaus, et al.
Disease Models & Mechanisms|December 21, 2022
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemicMaria Isabel Loza, Julija Hmeljak, Chas Bountra, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 19, 2005
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding propertiesDavid B Wainscott, Joseph H Krushinski, James E Audia, et al.
The Journal of Organic Chemistry|June 26, 1996
Resolution of delta-Lactams Provides Access to Nonracemic Benzoquinolinones: The Synthesis of LY300502 and LY300503Bret A. Astleford, James E. Audia, Jack Deeter, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2Christopher G Nasveschuk, Alexandre Gagnon, Shivani Garapaty-Rao, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Cold Spring Harbor Perspectives in Biology|April 3, 2016
Histone Modifications and CancerJames E Audia, Robert M Campbell
ACS Medicinal Chemistry Letters|March 19, 2020
Mentoring Matters in Drug DiscoveryMaria-Jesus Blanco, James E Audia
Life Sciences|July 11, 2002
Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in catsMary A Katofiasc, Jeffrey Nissen, James E Audia, et al.
Journal of Virology|March 18, 2021
Ilaprazole and other novel prazole-based compounds that bind Tsg101 inhibit viral budding of HSV-1/2 and HIV from cellsJonathan Leis, Chi-Hao Luan, James E Audia, et al.
The Journal of Organic Chemistry|November 1, 1996
"Pictet-Spengler-like" Synthesis of Tetrahydro-beta-carbolines under Hydrolytic Conditions. Direct Use of Azalactones as Phenylacetaldehyde EquivalentsJames E. Audia, James J. Droste, Jeffrey S. Nissen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 19, 2005
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brainVirginia L Lucaites, Joseph H Krushinski, John M Schaus, et al.
Disease Models & Mechanisms|December 21, 2022
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemicMaria Isabel Loza, Julija Hmeljak, Chas Bountra, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 19, 2005
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding propertiesDavid B Wainscott, Joseph H Krushinski, James E Audia, et al.
The Journal of Organic Chemistry|June 26, 1996
Resolution of delta-Lactams Provides Access to Nonracemic Benzoquinolinones: The Synthesis of LY300502 and LY300503Bret A. Astleford, James E. Audia, Jack Deeter, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2Christopher G Nasveschuk, Alexandre Gagnon, Shivani Garapaty-Rao, et al.
Pageof 4